Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katerina Ancevska Netkovska
Regulatory Considerations of Biosimilars and Clinical Dilema of Their Use
SANAMED
Related publications
Biosimilars: Key Regulatory Considerations and Similarity Assessment Tools
Biotechnology and Bioengineering
Applied Microbiology
Biotechnology
Bioengineering
Demystifying Biosimilars: Development, Regulation and Clinical Use
Future Oncology
Medicine
Cancer Research
Oncology
Clinical Use of Irinotecan:Current Status and Future Considerations
Oncologist
Cancer Research
Medicine
Oncology
Special Population Considerations and Regulatory Affairs for Clinical Research
Clinical Research and Regulatory Affairs
Pharmacology
Pharmaceutical Science
Will Regulatory and Financial Considerations Dampen Innovation in the Clinical Microbiology Laboratory?
mBio
Virology
Microbiology
Regulatory Requirements for the Development and Registration of Biosimilars in South Africa
GaBI Journal
Drug Guides
Pharmacy
Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment
Environmental and Molecular Mutagenesis
Mutagenesis
Toxicology
Health
Genetics
Epidemiology
An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cannabis Vaping and Health: Regulatory Considerations
Addiction
Medicine
Psychiatry
Mental Health